AstraZeneca (AZN)
Share price graph
Contact details
Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com
Company information
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Related news from City A.M.
The chief executive of pharmaceuticals giant AstraZeneca has written to staff to stifle rumours he is planning [...]
Shares in pharmaceutical giant AstraZeneca slid in morning trading after reports suggested its chief executive [...]
AstraZeneca today announced the sale of its migraine drug to Germany's Grunenthal. [...]
AstraZeneca today confirmed it priced a three-tranche bond offering totalling $2bn (£1.6bn) yesterday, which is [...]
FTSE 100 pharma giant AstraZeneca has sold the commercial rights to its Seloken heart medicines in Europe for [...]
Shares in AstraZeneca jumped nearly five per cent this morning, boosted by a successful trial of one of its [...]
One of Britain’s top captains of industry breathed a sigh of relief this week when he suggested to me that this [...]
The board of AstraZeneca was left with a bloody nose after nearly 40 per cent of voting shareholders opposed [...]
AstraZeneca said it will turn a corner in the second half of 2017 after facing plummeting revenues as drug patents [...]
Some of Britain’s biggest companies are set to face a fresh bout of shareholder rebellions over high levels [...]
Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]
Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]
Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]
AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]
AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]
Content tagged with "AstraZeneca"